carmellcosmetics.com (XAGE): O‘sishni hisobga olgan narx-foyda koeffitsiyenti
Longevity Health Holdings (XAGE) plazma protein formulalari orqali qanday qilib premium narxlarni ta'minlay oladi? GURU.Markets grafigidagi narx o'zgarishlari hisoblangan PEG darajasi 0.00 ushbu parametr darajasini belgilaydigan tendentsiyani aks ettiradi. Yechim lyuks segmenti uchun bio-kosmetika ishlab chiqishda yotadi, garchi tijorat sotuvlariga o'tish sezilarli xarajatlarni va kengayish davrida operatsion xarajatlarning vaqtincha oshishini talab qilsa-da.
Longevity Health Holdings (XAGE) kompaniyasi koʻrsatkichlari kesimi va tahlili
- joriy kotirovkalar va o'rtacha qiymat prognozi:
- birja kapitallashuvi ma'lumotlari:
- biznesning balans baholash tafsilotlari:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Qarzning kapitalga nisbati Longevity Health Holdings|XAGE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi carmellcosmetics.com|XAGE - Kompaniyaning jamlangan qarzlari|Qarzning sof aktivlarga nisbati Longevity Health Holdings Inc|XAGE - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Longevity Health Holdings|Tezkor likvidlik carmellcosmetics.com
- foyda va bozor koeffitsiyentlari statistikasi:
XAGE - Sof foyda|Kompaniya foydasi prognozi Longevity Health Holdings|XAGE - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning kelajakdagi foydaga nisbati Carmell Corp|XAGE - Narx-foyda va o‘sish multiplikatori|Kompaniya qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Longevity Health Holdings Inc|XAGE - Eskirish chegirilmasdan oldingi operatsion foyda|Sirpanuvchi yil uchun bir aksiya uchun foyda Longevity Health Holdings|XAGE - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi carmellcosmetics.com|XAGE - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi Longevity Health Holdings
Kompaniyaning umumiy tahlili:Longevity Health Holdings
Longevity Health Holdings (XAGE) kompaniyasining operatsion muvaffaqiyatini ob'ektiv baholash uchun investorlar biznesning bozor qiymatini uning foyda dinamikasi bilan bog'lashlari kerak. P/E koeffitsientini daromad o'sish sur'atlariga bo'luvchi PEG koeffitsienti orqali past baholanganlik darajasini tahlil qilish orqali, makroiqtisodiy sikllardan qat'i nazar, Longevity Health Holdings (XAGE) uchun yuqori marjali estetik tibbiyotni kengaytirishning fundamental barqarorligini tasdiqlash va shu orqali haddan tashqari qimmat aktivni sotib olish xavfini bartaraf etish mumkin.
Raqobatdosh kompaniyalar
HCA - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Tenet THC|FMS: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|SOLV: Narx-foyda va o‘sish multiplikatori|encompasshealth.com - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|uhsinc.com (UHS) - Narxning foydaga va o‘sish sur’atiga nisbati|DVA (DaVita HealthCare Partners) - Narxning foydaga va o‘sish sur’atiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati RadNet Corp|O‘sish sur’atiga tuzatilgan narx-foyda Option Care Corp OPCH|Narxning foydaga va o‘sish sur’atiga nisbati Surgery Partners, Inc. (SGRY)|premierinc.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori EYE (National Vision)|Narxning sof foyda o‘sishiga nisbati Progyny Inc|Ardent Health Partners Inc - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Select Medical Inc.|ASTH (Astrana Health, Inc.) - Narx-foyda va o‘sish multiplikatori|MD (Pediatrix Medical Group) - Narxning foydaga va o‘sish sur’atiga nisbati|USPH (US Physical Therapy) - PEG multiplikatori|Pennant Group (PNTG) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori ORGO (Organogenesis Inc.)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati NUTX|Auna SA - Narx-foyda va o‘sish multiplikatori|sbc-holdings.com (SBC) - O‘sish sur’atiga tuzatilgan narx-foyda|EOLS: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti CYH (CHS)|SKIN: PEG multiplikatori|MediWound - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|BTMD (biote Corp.) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda thejoint.com JYNT|PEG multiplikatori DCGO|PEG multiplikatori p3hp.org (PIII)|Narxning foydaga va o‘sish sur’atiga nisbati Gain Therapeutics, Inc. GANX|euda.com - Narxning foydaga va o‘sish sur’atiga nisbati|BMGL: Narx-foyda va o‘sish multiplikatori|CollPlant Biotechnologies - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|CUPR: PEG multiplikatori|Concord Medical Services Holdings - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narx-foyda va o‘sish multiplikatori AMS|MRM: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ALBT|DHAI (dih.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati NewGenIvf NIVF|ATI Physical Therapy Inc. (ATIP) - O‘sish sur’atiga tuzatilgan narx-foyda|CMAX - Narxning foydaga va o‘sish sur’atiga nisbati|KDLY: Narxning foydaga va o‘sish sur’atiga nisbati|MODV: PEG multiplikatori|O‘sishni hisobga olgan narx-foyda koeffitsiyenti NVOS|SSY (SunLink Health Systems Inc.) - PEG multiplikatori|IMAC Holdings Inc (BACK) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
